Syndax Pharmaceuticals (SNDX) Other Non-Current Liabilities (2015 - 2025)
Syndax Pharmaceuticals (SNDX) posted quarterly Other Non-Current Liabilities of $4.8 million for Q2 2025, up 165.28% quarter-over-quarter from $1.8 million in Q1 2025.
Syndax Pharmaceuticals (SNDX) Other Non-Current Liabilities (2015 - 2025) Analysis & Trends
Syndax Pharmaceuticals' Other Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $4.8 million for Q2 2025.
- In Q2 2025, Other Non-Current Liabilities changed N/A year-over-year to $4.8 million; the TTM figure through Jun 2025 stood at $4.8 million (changed N/A YoY), while the FY2024 annual figure was $307000.0, changed N/A from the prior year.
- Other Non-Current Liabilities for Q2 2025 stood at $4.8 million, up from $1.8 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $4.8 million in Q2 2025, with the low at $307000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Syndax Pharmaceuticals | 1.77 Bn | 1.22 Bn | 60.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 4.78 Mn |
| Mar 31, 2025 | 1.80 Mn |
| Dec 31, 2024 | 307,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Sep 30, 2020 | 2,000.00 |
| Jun 30, 2020 | 3,000.00 |
| Mar 31, 2020 | 4,000.00 |
| Dec 31, 2019 | 5,000.00 |
| Sep 30, 2019 | 6,000.00 |
| Jun 30, 2019 | 7,000.00 |
| Mar 31, 2019 | 7,000.00 |
| Dec 31, 2018 | 136,000.00 |
| Sep 30, 2018 | 148,000.00 |
| Jun 30, 2018 | 311,000.00 |
| Mar 31, 2018 | 312,000.00 |
| Dec 31, 2017 | 310,000.00 |
| Sep 30, 2017 | 267,000.00 |
| Jun 30, 2017 | 214,000.00 |
| Mar 31, 2017 | 148,000.00 |
| Dec 31, 2016 | 288,000.00 |